Importantly, the study confirmed that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo, with no treatment-related serious adverse events or study withdrawals occurring
The FDA has flagged BPC-157 because of risks like immunogenicity (it could trigger immune reactions), peptide impurities, and lack of human safety data
Or, somehow, do both simultaneously
A single unit conversion error between milligrams and micrograms can produce a tenfold dosing mistake
Brightening is about improving radiance, reducing the look of dullness, and supporting a more even-toned complexion
The syndrome is characterised by rapid changes in solute concentrations in the brain during dialysis